About Galvanize Therapeutics
Galvanize Therapeutics is a private company based in Redwood City, California. It has reported $144,645,411 raised in four offerings on Form D since March 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 7, 2025 | Sep 11, 2025 | $96,130,465of $141.0M target | 28 | $3.4M | EquityRule 506(b) | Form D ↗ |
| Mar 9, 2022 | Mar 22, 2022 | $4,000,000fully sold | 1 | $4.0M | DebtRule 506(b) | Form D ↗ |
| Feb 23, 2022 | Mar 9, 2022 | $2,000,000fully sold | 1 | $2.0M | DebtRule 506(b) | Form D ↗ |
| Oct 8, 2015 | Mar 13, 2019amended Nov 18, 2019 | $42,514,946of $43.0M target | 1 | $42.5M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, four offerings | $144,645,411 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Galvanize Therapeutics's Form D filed Sep 11, 2025.
DG
Doug Godshall
Executive officer and director
JW
Jonathan Waldstreicher
Executive officer
AP
Antoine Papiernik
Director
DL
David Lewis
Director
SA
SH
Seth Harrison
Director
ZS
Zack Scott
Director